Birth control pill study reveals drug interaction risks
NCT ID NCT07215806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a drug called evobrutinib changes the way birth control pills work in 20 healthy women. Participants took both medications and had their blood tested to measure hormone levels. The goal was to see if evobrutinib affects how the body processes birth control, which helps doctors understand potential interactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuvisan GmbH
Neu-Ulm, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test